Group One Trading
VRDN icon

Group One Trading’s Viridian Therapeutics VRDN Stock Holding History

Group One Trading’s Portfolio VRDN Stock Details VRDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$12.2K Buy
625
+396
+173% +$11.8K ﹤0.01% 6256
2025
Q4 		$7.13K Buy
+229
New +$6.28K ﹤0.01% 7003
2025
Q1 		– Sell
-47,995
Closed -$818K – 8434
2024
Q4 		$920K Buy
47,995
+7,233
+18% +$157K ﹤0.01% 2647
2024
Q3 		$927K Buy
40,762
+30,898
+313% +$505K ﹤0.01% 2365
2024
Q2 		$128K Buy
+9,864
New +$137K ﹤0.01% 3758
2024
Q1 		– Sell
-17
Closed -$330 – 8030
2023
Q4 		$370 Sell
17
-2,628
-99% -$41.5K ﹤0.01% 7120
2023
Q3 		$40.6K Sell
2,645
-3,817
-59% -$72.8K ﹤0.01% 5297
2023
Q2 		$154K Buy
+6,462
New +$166K ﹤0.01% 4205

Other funds holding VRDN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return